{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:08:33Z","timestamp":1792026513938,"version":"4.4.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Infectious"},{"DOI":"10.13039\/100006292","name":"Diseases Society of America\u2019s","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006292","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Emerging Researchers\/Clinicians Mentorship"},{"DOI":"10.13039\/501100007520","name":"MMA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007520","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Nirsevimab is a monoclonal antibody with demonstrated efficacy in preventing respiratory syncytial virus (RSV) infections in infants. Because acute respiratory tract infections (ARTIs), including viral infections, often lead to antibiotic prescribing, we aimed to determine the effectiveness of nirsevimab on antibiotic prescribing among infants with medically attended ARTIs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A primary care attendee cohort was established using electronic health record data from 32 diverse practices across a healthcare network to emulate a target trial comparing nirsevimab to no treatment among infants &amp;lt;8 months. Eligible infants were seen at a primary care practice within 14 days of life. Primary outcomes included time to first antibiotic prescription for (1) outpatient ARTIs, (2) outpatient encounters for bronchiolitis, and (3) RSV-related hospitalizations. Nirsevimab effectiveness was calculated as 1 minus the risk ratio for each primary outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 15 341 patients who met inclusion criteria, 7413 received nirsevimab. Compared with no treatment, nirsevimab administration led to a 14.4% (95% CI: 7.8%, 20.6%) reduction in antibiotic prescribing for outpatient ARTIs, a 40.3% (95% CI: 25.1%, 52.5%) reduction in antibiotic prescribing for outpatient bronchiolitis, and a 69.4% (95% CI: 4.8%, 90.1%) reduction in antibiotic prescribing for RSV-related hospitalizations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Nirsevimab administration in primary care reduced antibiotic use for ARTIs in both ambulatory and inpatient settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciag406","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:41:30Z","timestamp":1784029290000},"page":"e487-e494","source":"Crossref","is-referenced-by-count":2,"title":["The Effectiveness of Nirsevimab on Antibiotic Use in Children Using Target Trial Emulation"],"prefix":"10.1093","volume":"83","author":[{"given":"Mahaa M","family":"Ahmed","sequence":"first","affiliation":[{"name":"Clinical Futures, Children's Hospital of Philadelphia , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1915-4275","authenticated-orcid":false,"given":"Torsten","family":"Joerger","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Infectious Diseases, University of Pennsylvania Perelman School of Medicine and Children's Hospital of Philadelphia , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Wang","sequence":"additional","affiliation":[{"name":"Clinical Futures, Children's Hospital of Philadelphia , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8225-4554","authenticated-orcid":false,"given":"Yun","family":"Li","sequence":"additional","affiliation":[{"name":"Clinical Futures, Children's Hospital of Philadelphia , Philadelphia, Pennsylvania ,","place":["USA"]},{"name":"Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania School of Medicine , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3076-3186","authenticated-orcid":false,"given":"Jeffrey S","family":"Gerber","sequence":"additional","affiliation":[{"name":"Clinical Futures, Children's Hospital of Philadelphia , Philadelphia, Pennsylvania ,","place":["USA"]},{"name":"Department of Pediatrics, Division of Infectious Diseases, University of Pennsylvania Perelman School of Medicine and Children's Hospital of Philadelphia , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"2026100713441096700_ciag406-B1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.15585\/mmwr.mm7214a1","article-title":"Seasonality of respiratory syncytial virus\u2014United States, 2017-2023","volume":"72","author":"Hamid","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026100713441096700_ciag406-B2","doi-asserted-by":"crossref","first-page":"e2023062574","DOI":"10.1542\/peds.2023-062574","article-title":"Respiratory syncytial virus-associated hospitalizations among children &lt;5 years old: 2016 to 2020","volume":"153","author":"Curns","year":"2024","journal-title":"Pediatrics"},{"key":"2026100713441096700_ciag406-B3","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMoa0804877","article-title":"The burden of respiratory syncytial virus infection in young children","volume":"360","author":"Hall","year":"2009","journal-title":"N Engl J Med"},{"key":"2026100713441096700_ciag406-B4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1542\/peds.2011-2879","article-title":"Trends of outpatient prescription drug utilization in US children, 2002\u20132010","volume":"130","author":"Chai","year":"2012","journal-title":"Pediatrics"},{"key":"2026100713441096700_ciag406-B5","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/cid\/ciac811","article-title":"Impact of respiratory infection and chronic comorbidities on early pediatric antibiotic dispensing in the United States","volume":"76","author":"Kissler","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026100713441096700_ciag406-B6","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/infdis\/jiae543","article-title":"Clinical characteristics and in-hospital outcomes associated with respiratory syncytial virus vs other viral acute lower respiratory infections in hospitalized children younger than 2 years","volume":"231","author":"Ozturk","year":"2025","journal-title":"J Infect Dis"},{"key":"2026100713441096700_ciag406-B7","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/INF.0000000000001981","article-title":"Antibiotic overuse in children with respiratory syncytial virus lower respiratory tract infection","volume":"37","author":"van Houten","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"2026100713441096700_ciag406-B8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S2213-2600(24)00367-9","article-title":"Burden of RSV infections among young children in primary care: a prospective cohort study in five European countries (2021\u201323)","volume":"13","author":"Hak","year":"2025","journal-title":"Lancet Respir Med"},{"key":"2026100713441096700_ciag406-B9","doi-asserted-by":"crossref","first-page":"e2020040295","DOI":"10.1542\/peds.2020-040295","article-title":"Antibiotic stewardship in pediatrics","volume":"147","author":"Gerber","year":"2021","journal-title":"Pediatrics"},{"key":"2026100713441096700_ciag406-B10","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1017\/ash.2025.10044","article-title":"Temporal trends in vaccination and antibiotic use among young children in the United States, 2000\u20132019","volume":"5","author":"Eiden","year":"2025","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"2026100713441096700_ciag406-B11","doi-asserted-by":"crossref","first-page":"e20170441","DOI":"10.1542\/peds.2017-0441","article-title":"Trends in antibiotic use by birth season and birth year","volume":"140","author":"Kinlaw","year":"2017","journal-title":"Pediatrics"},{"key":"2026100713441096700_ciag406-B12","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3201\/eid2601.191110","article-title":"Effect of pediatric influenza vaccination on antibiotic resistance, England and Wales","volume":"26","author":"Chae","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"2026100713441096700_ciag406-B13","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1093\/jpids\/piae030","article-title":"New and emerging passive immunization strategies for the prevention of RSV infection during infancy","volume":"13","author":"Domachowske","year":"2024","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2026100713441096700_ciag406-B14","doi-asserted-by":"crossref","first-page":"e250380","DOI":"10.1001\/jamanetworkopen.2025.0380","article-title":"Estimated effectiveness of nirsevimab against respiratory syncytial virus","volume":"8","author":"Xu","year":"2025","journal-title":"JAMA Netw Open"},{"key":"2026100713441096700_ciag406-B15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S2352-4642(25)00093-8","article-title":"Real-world effectiveness of nirsevimab against respiratory syncytial virus disease in infants: a systematic review and meta-analysis","volume":"9","author":"Sumsuzzman","year":"2025","journal-title":"Lancet Child Adolesc Health"},{"key":"2026100713441096700_ciag406-B16","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/jama.2025.13350","article-title":"Transparent reporting of observational studies emulating a target trial\u2014the TARGET statement","volume":"334","author":"Cashin","year":"2025","journal-title":"JAMA"},{"key":"2026100713441096700_ciag406-B17","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJMoa2110275","article-title":"Nirsevimab for prevention of RSV in healthy late-preterm and term infants","volume":"386","author":"Hammitt","year":"2022","journal-title":"N Engl J Med"},{"key":"2026100713441096700_ciag406-B18","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1056\/NEJMoa2314885","article-title":"Nirsevimab and hospitalization for RSV bronchiolitis","volume":"391","author":"Assad","year":"2024","journal-title":"N Engl J Med"},{"key":"2026100713441096700_ciag406-B19","doi-asserted-by":"publisher","author":"Su","DOI":"10.48550\/arXiv.2402.12083"},{"key":"2026100713441096700_ciag406-B20","author":"Gravestock"},{"key":"2026100713441096700_ciag406-B21","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology"},{"key":"2026100713441096700_ciag406-B22","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.2337\/dc12-1756","article-title":"Statins and risk of diabetes: an analysis of electronic medical records to evaluate possible bias due to differential survival","volume":"36","author":"Danaei","year":"2013","journal-title":"Diabetes Care"},{"key":"2026100713441096700_ciag406-B23","doi-asserted-by":"crossref","first-page":"e2025070790","DOI":"10.1542\/peds.2025-070790","article-title":"Disparities in nirsevimab uptake across a pediatric primary care network","volume":"156","author":"Ahmed","year":"2025","journal-title":"Pediatrics"},{"key":"2026100713441096700_ciag406-B24","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1542\/peds.2012-2500","article-title":"Racial differences in antibiotic prescribing by primary care pediatricians","volume":"131","author":"Gerber","year":"2013","journal-title":"Pediatrics"},{"key":"2026100713441096700_ciag406-B25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1471-2431-14-199","article-title":"Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation","volume":"14","author":"Feudtner","year":"2014","journal-title":"BMC Pediatr"},{"key":"2026100713441096700_ciag406-B26","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am J Epidemiol"},{"key":"2026100713441096700_ciag406-B27","doi-asserted-by":"crossref","DOI":"10.1201\/9781003456285","volume-title":"Statistical inference","author":"Casella","year":"2024"},{"key":"2026100713441096700_ciag406-B28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jaci.2024.03.025","article-title":"Antibiotics taken within the first year of life are linked to infant gut microbiome disruption and elevated atopic dermatitis risk","volume":"154","author":"Hoskinson","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"2026100713441096700_ciag406-B29","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1056\/NEJMoa2309189","article-title":"Nirsevimab for prevention of hospitalizations due to RSV in infants","volume":"389","author":"Drysdale","year":"2023","journal-title":"N Engl J Med"},{"key":"2026100713441096700_ciag406-B30","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S2352-4642(22)00321-2","article-title":"Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials","volume":"7","author":"Sim\u00f5es","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"key":"2026100713441096700_ciag406-B31","doi-asserted-by":"crossref","first-page":"658\u2013","DOI":"10.1093\/cid\/ciaf564","article-title":"Impact of RSV immunization on the rate of pediatric acute otitis media: a time-series analysis","volume":"82","author":"Fafi","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026100713441096700_ciag406-B32","doi-asserted-by":"crossref","first-page":"ofaa223","DOI":"10.1093\/ofid\/ofaa223","article-title":"The impact of influenza vaccination on antibiotic use in the United States, 2010\u20132017","volume":"7","author":"Klein","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2026100713441096700_ciag406-B33","doi-asserted-by":"crossref","first-page":"1800081","DOI":"10.2807\/1560-7917.ES.2018.23.47.1800081","article-title":"Impact of pneumococcal conjugate vaccines introduction on antibiotic resistance of Streptococcus pneumoniae meningitis in children aged 5 years or younger, Israel, 2004 to 2016","volume":"23","author":"Ben-Shimol","year":"2018","journal-title":"Euro Surveill"},{"key":"2026100713441096700_ciag406-B34","first-page":"94","article-title":"Acute otitis media and respiratory virus infections","volume":"8","author":"Ruuskanen","year":"1989","journal-title":"Pediatr Infect Dis J"},{"key":"2026100713441096700_ciag406-B35","doi-asserted-by":"crossref","first-page":"e1001776","DOI":"10.1371\/journal.pmed.1001776","article-title":"Association between respiratory syncytial virus activity and pneumococcal disease in infants: a time series analysis of US hospitalization data","volume":"12","author":"Weinberger","year":"2015","journal-title":"PLoS Medicine"},{"key":"2026100713441096700_ciag406-B36","doi-asserted-by":"crossref","first-page":"102428","DOI":"10.1016\/j.eclinm.2024.102428","article-title":"Exposure to prescribed medication in early life and impacts on gut microbiota and disease development","volume":"68","author":"Huang","year":"2024","journal-title":"EClinicalMedicine"},{"key":"2026100713441096700_ciag406-B37","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12941-022-00535-1","article-title":"Early-life antibiotic exposure increases the risk of childhood overweight and obesity in relation to dysbiosis of gut microbiota: a birth cohort study","volume":"21","author":"Li","year":"2022","journal-title":"Ann Clin Microbiol Antimicrob"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciag406\/70478965\/ciag406.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/83\/3\/e487\/70478965\/ciag406.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/83\/3\/e487\/70478965\/ciag406.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:44:23Z","timestamp":1791395063000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/83\/3\/e487\/8750980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,8,6]]},"published-print":{"date-parts":[[2026,10,7]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciag406","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9,15]]},"published":{"date-parts":[[2026,8,6]]}}}